AXA Framlington Biotech Fund GBP Z Acc

Register to Unlock Ratings
DomicileUnited Kingdom
Legal StructureUnit Trust
Inception Date16/04/2012
Fund Advisor(s)
AXA Investment Managers UK Ltd
Fund ManagerLinden Thomson
Manager Start Date05/07/2012
Fund ManagerPeter Hughes
Manager Start Date01/04/2018
2014, UCL, Ph.D.
2010, University of Surrey, M.S.
Peter is a Portfolio Manager in our Framlington Equities expertise and has specialised in bi-otech and longevity within its global strategies since joining the firm in 2015. Prior to AXA IM, Peter worked at Architas in roles covering investment research and relationship man-agement. Peter completed a PhD in biochemistry at University College London, working on a drug development project in a multidisciplinary research group collaborating with GSK. He has a master's degree in chemistry from the University of Surrey and holds the Investment Man-agement Certificate. He is also an ambassador for the Royal Marsden Cancer Charity.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(